Zhejiang Teruisi Biopharmaceutical, Inc.
http://www.teruisipharm.com/#
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Zhejiang Teruisi Biopharmaceutical, Inc.
Finance Watch: VC Mega-Rounds Surge Again, Led By Acelyrin’s $300m Series C
Private Company Edition: Acelyrin will use its latest funding for Phase III development of izokibep in inflammatory diseases. Also, ArsenalBio raised $220m to take its programmable cell therapies into the clinic and RayzeBio’s $160m series D round will fund clinical trials for its radiopharmaceuticals.
HutchMed Set to Lead China Biotech Fundraising In June
The China-based biopharma company is seeking up to $602.8m gross in its Hong Kong IPO.
Mount Sinai Taps Smith For New Effort In Entrepreneurship
Managing Partner at Ascent Biomedical Ventures Geoffrey Smith recently began a new role at Mount Sinai Medical School that is helping academics translate their knowledge into real-world commercial opportunities.
Selected Start-Ups (09/2009)
In Vivo briefly describes these recently founded companies: Acetylon Pharmaceuticals, Avineuro Pharmaceuticals, Nanovis, TargAnox, TheraCell and Treventis.
Company Information
- Industry
- Biotechnology
- Pharmaceuticals
- Other Names / Subsidiaries
-
- Zhejiang Teruisi Pharmaceutical Inc.
- Zhejiang Tellus Pharmaceutical Co., Ltd.
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice